Expedited Pathways Comparisons - US EU CHN

Published on: Oct 19, 2021

This presentation from Parexel's virtual roundtable, entitled "Making expedited regulatory pathways work for global drug development programs" outlines regional comparisons of expedited pathways in US, EU and China.


Open PDF

Return to Insights Center

Related Insights

Article

Near-term strategies for biotech drug developers facing shifting healthcare dynamics

Feb 14, 2024

Playbook

What emerging trends in the FDA’s most coveted designations might tell us

Feb 8, 2024

Webinar

Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development

May 6, 2025

Blog

Focusing on value drivers to reduce risk in early-stage drug development

Jan 6, 2025

Webinar

Accelerated Early Phase Decision-Making – Insider Insights to Speed Development

Jan 7, 2025

Article

How emerging biotechs can enter the Chinese market and prosper

Jan 18, 2022

Blog

Proof of product safety and efficacy: how to move ahead successfully in Phase 2 clinical development

Jan 22, 2025

Blog

Overcoming risks in Phase 3 trials to accelerate time to market

Jan 22, 2025

Playbook

Streamlining development in the EU: Strategies for smoother CTA submissions

Feb 27, 2025

Blog

Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial

Nov 19, 2021

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Playbook

Early-phase development strategies for navigating regulatory complexity in the EU

Apr 29, 2024

Related Insights

Article

Near-term strategies for biotech drug developers facing shifting healthcare dynamics

Feb 14, 2024

Playbook

What emerging trends in the FDA’s most coveted designations might tell us

Feb 8, 2024

Webinar

Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development

May 6, 2025

Blog

Focusing on value drivers to reduce risk in early-stage drug development

Jan 6, 2025

Webinar

Accelerated Early Phase Decision-Making – Insider Insights to Speed Development

Jan 7, 2025

Article

How emerging biotechs can enter the Chinese market and prosper

Jan 18, 2022

Show more